Fig.Ā 2From: Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparumSusceptibility of different P. falciparum strains to SC83288 and dihydroartemisinin. a and b Growth inhibition of NF54 and the artemisinin resistant derivative NF54ART carrying the PfK13 C580Y mutation by artemisinin (a) and SC83288 (b) in a standard cell proliferation assay with an exposure time of 72Ā h. c and d Growth inhibition of Dd2 and the SC83288 resistant derivative Dd2SC by artemisinin (c) and SC83288 (d). MeanāĀ±āSEM of 6ā13 independent determinationsBack to article page